V-Mart Retail Limited has announced a board meeting to consider the financial results for the quarter and half-year. Separately, the market is seeing shifts with Nifty 200 re-rating its composition, possibly triggering ~₹16,000 crore in buy-sell activity due to index rebalancing, impacting several key sectors. In consumer trends, Eli Lilly’s weight-loss drug Mounjaro has gained approval in a new ready-to-use KwikPen form in India, expanding dosage options and intensifying competition with Novo Nordisk’s Wegovy. This could accelerate adoption of obesity treatments amid India’s growing population facing weight-related health issues. Steel demand remains subdued due to weak infrastructure activity and monsoon effects.